The Cytotoxic Effect on HepG2 Cell Line and In Vitro, In Silico Evaluation of 1,2,4‐Triazine Compounds as Inhibitors of Acetylcholinesterase and Glutathione S‐Transferase

Documenti analoghi

• Pyrimidine Based Inhibitors Targeting Glutathione S‐Transferase in Phase II Detoxification: Antioxidant, ADMET, Docking, and Molecular Dynamics Evaluation
  di: Fikret Türkan, et al.
  Pubblicazione: (2025)
• New methyl/benzyl‐1,2,4‐triazole‐3‐one Derivatives: Synthesis, Characterization (IR, NMR), Antidiabetic, Anti‐Alzheimer, and Molecular Docking Study
  di: Fatih Çelik, et al.
  Pubblicazione: (2025)
• Microwave‐Assisted Synthesis and In Vitro Anti‐Alzheimer Evaluation of Novel 1,3,5‐Triazine‐Nicotinic Hydrazide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors
  di: Tutumoni Kalita, et al.
  Pubblicazione: (2026)
• The Study of the Antitumor Effects and Molecular Mechanisms of Byakangelicol on HepG2 Cells
  di: Chang Wang, et al.
  Pubblicazione: (2026)
• Sulfo‐N‐Succinimidyl Oleate Sodium as CD36 Inhibitor: Dose Optimization and Its Effects on FFA Uptake, Inflammation, and ER Stress in HepG2 Cells
  di: Widya Wasityastuti, et al.
  Pubblicazione: (2025)